You are here

Evaluation of an RNA interference screen-derived mitotic and ceramide pathway meta- gene in paclitaxel-treated primary ER-/PR-/ERBB2- breast cancer: a retrospective analysis of five clinical trials.

TitleEvaluation of an RNA interference screen-derived mitotic and ceramide pathway meta- gene in paclitaxel-treated primary ER-/PR-/ERBB2- breast cancer: a retrospective analysis of five clinical trials.
Publication TypeJournal Article
Year of Publication2010
AuthorsJuul, N, Eklund, AC, Li, Q, Burrell, RA, Gerlinger, M, Valero, V, Andreopoulou, E, Esteva, FJ, Symmans, FW, Desmedt, C, Haibe-Kains, B, Sotiriou, C, Pusztai, L, Szallasi, Z, Swanton, C
JournalLancet Oncology

Theme by Danetsoft and Danang Probo Sayekti inspired by Maksimer